This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

Funding competition: biomedical catalyst 2017 round 1 18 January 2017

UK businesses can apply for a share of up to £10 million to develop innovative ideas that will help solve healthcare challenges.

> Read More

The University of Leeds and Covance launch new MSc in Biopharmaceutical Development 18 January 2017

The University of Leeds and Covance have formed a partnership to train future leaders in the biopharmaceutical industry.

> Read More

F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318 10 January 2017

MANCHESTER, UK – 09 January 2017 – F2G Ltd, a UK Biotech developing novel therapies for life threatening fungal infections, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted orphan drug status to its lead clinical candidate.

> Read More